'If she contests it, then these people will have to fight it in court.'
The number of cases being admitted and investigated by the Competition Commission of India has fallen drastically in recent years.
Aneesh Phadnis and Veena Mani find out what the manufacturers and the hospitals have to say.
Ministerial consultations on, with recognition of the potential, and the need to not classify it under the same rules as for pharmaceuticals.
Both benchmark indices were driven by strong gains in IT, teck, oil and gas, pharma and banking shares amid earnings optimism.
Slapped with Rs 242-crore fine by US authorities for rule violations at Toansa unit, say sources; 2nd such hefty rap in the recent past from US regulators for bending rules.
Exports from Ranbaxy plants at Toansa and Dewas to Europe will remain suspended as probes are continuing even as Indian authorities have withdrawn the certification of manufacturing standards from one of the units, European health regulator EMA said today.
Infosys, Wipro and HUL among the top losers for the day.
IT, pharma and FMCG stocks are the top performers in 2013.
Face NPPA fine for overcharging on anti-asthma drug
'Sharapova has been a US resident since early in her career, which does bring in a question of how or why she is using a drug that is not licensed there'
Here is some interesting information released by the government in response to questions posed by MPs in Parliament on Tuesday.
Companies that are developing biosimilars (for regulated markets) or have portfolio of new chemical entities (NCEs) under development.
Modi said the ease of doing business ranking improved because the government initiated reforms to end difficulties in the lives of people.
Wealth of the richest 62 people has risen 44% in the five years since 2010, while that of the bottom half fell by 41%
Britain's vote to leave the European Union means uncertainty for markets and companies as London initiates at least two years of negotiations with the EU.
Sun Pharmaceutical Industries will take a call on whether to shut Ranbaxy's troubled factories or make changes in the top management of the latter only after its $4-billion acquisition deal is complete.
Negotiators from were expected to meet in New Delhi on August 28.
It hopes to turn around Ranbaxy within four years of closing the deal by improving efficiency and resolving all regulatory issues
'The failures of private businessmen have set back the process of market-oriented reform, though that is the only way forward,' argues T N Ninan.
India on Monday raised serious concerns over the USFDA's audit inspections of Indian pharma companies and 'disproportionate penalties' in some instances and said it would submit a discussion document on the issues to the US.
Sun Pharma would have to do a lot of work to get USFDA to revoke the ban on Ranbaxy facilities but it has not put any time-frame for this, company ChairmanIsrael Makov said.
Benchmark indices finished higher on hopes of economic reforms
'From India to Indiana, there has always been a sense of hope, optimism, and goodness.'
Ranbaxy's US factory, Ohm Laboratories, is learnt to have got a clean chit from the American regulator. This US facility was under surveillance of the Food and Drug Administration (FDA) since the end of 2012.
Sun Pharma's Dilip Shanghvi is India's richest person.
Some investors warned of a coming British or even global recession as sterling collapsed to hit its lowest since 1985.
Lower IT exports will raise India's dependence on capital flows to fund imports.
'And the top 10 per cent will grow because they have to serve the market.'
More lucrative routinely prescribed drugs are at higher risk of failing quality standards
.jpg)
The company has been reported to be retrenching staff.
.jpg)
Firms are mandated to change prices of medicines within 45 days of NPPA's notification.
The number of small units has come down drastically, as large companies have expanded their manufacturing capacity.
Capital goods, IT, auto and pharmaceuticals lead gains for the financial year
FDA had also issued warning letters to Ranbaxy's Paonta Sahib and Dewas facilities as it found extensive problems and deviations from manufacturing norms.
Senior police officers were among 13 people killed on Monday when a Taliban suicide bomber blew himself up targeting them during a protest rally outside Pakistan's Punjab assembly in Lahore that also wounded 60 others.
On her maiden visit to India, US Food and Drug Administrator Margaret A Hamburg has said recent lapses in quality by a handful of pharma companies has overshadowed the good things done by other Indian companies, who emphasise on quality products and practices.
UK's largest retailer Tesco, Singapore Airlines and Etihad queued up to invest in India as a persistent UPA threw open more sectors to foreign investments with indications of more big ticket deals to be announced in the new year.
Rediff.com does a quick checklist on what the two manifestos have to say on hot-button issues of the day.
After recognising its adverse health effects, the govt has now dismissed its own lab reports to conclude that the evidence against plastic is insufficient.
